Detection of lipoprotein(a) in intraparenchymal cerebral vessels: Correlation with vascular pathology and clinical history

Experimental and Molecular Pathology

Volumn 71, Issue 2, 2001, Pages 99-105

  Jamieson, Dara G ^a   Fu, Li ^b   Lavi, Ehud ^b   Usher, David C ^c  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

Author keywords

Aorta; Apolipoprotein (a); Apolipoprotein B; Arteries; Atherosclerosis; Blood vessels; Carotid artery; Lipoprotein (a); Low density lipoprotein

Indexed keywords

LIPOPROTEIN A; MONOCLONAL ANTIBODY;

ARTICLE; ATHEROSCLEROSIS; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN CIRCULUS ARTERIOSUS; BRAIN HYPOXIA; BRAIN INJURY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN METABOLISM; PATHOGENESIS; PROTEIN LIPID INTERACTION;

EID: 0034781130     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2001.2384     Document Type: Article

References (38)

1. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients
2. Lipoprotein (a) in the arterial wall
3. Origins of human atherosclerotic plaque: The role of altered gene expression
4. A new serum type system in man: The Lp system
5. Lp(a) lipoprotein and pre B1 lipoprotein in patients with coronary heart disease
6. Case-control study of serum lipoprotein(a) and apolipoprotein-A-I and apolipoprotein-B in stroke in the young
7. Lp(a)/pre-B1-lipoprotein, serum lipids and atherosclerotic disease
8. Inhibition of tumor-necrosis-factor-alpha reduces focal cerebral ischemic-injury in the spontaneously hypertensive rat
9. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
10. Serum lipids in angiographically assessed coronary atherosclerosis
11. Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries
12. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
13. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
14. Many roads lead to atheroma
15. Defensin stimulates the binding of Lp(a) to human vascular endothelial and smooth muscle cells
16. Lipoprotein Lp(a). A risk factor for myocardial infarction
17. Apolipoprotein B localization in coronary atherosclerotic plaques from cynomolgus monkeys
18. Association of levels of lipoprotein (a) and other lipoproteins with cerebrovascular-disease in the turkish population
19. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels: A potential role for endothelial cells in lesion formation
20. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease
21. Silent cerebral infarction is associated with hypercoagulability, endothelial-cell damage, and high lp(a) levels in elderly Japanese
22. Lipoprotein(a) in health and disease
23. Platelet-activating factor in stroke and brain injury
24. Interleukin-1 beta mRNA expression in ischemic rat cortex
25. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
26. A potential basis for the thrombotic risks associated with lipoprotein(a)
27. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
28. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries
29. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
30. The pathogenesis of atherosclerosis: An update
31. High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction
32. Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats
33. A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies
34. The mysteries of lipoprotein(a)
35. Lipoprotein(a) in patients with acute cerebral-ischemia
36. Hypertension, lipoprotein (a), and apolipoprotein A-I as risk factors for stroke in the Chinese
37. Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions
38. Lipoprotein (a) as a strong indicator for cerebrovascular disease